TOP NEWS

Arena Pharmaceuticals Looks To Raise $150M In Stock Offering

San Diego-based biopharmaceuticals developer Arena Pharmaceuticals said on Tuesday that it is looking to raise $150.0M in a public offering. The company, which is already publicly listed on the NASDAQ as ARNA, said that Citigroup, Leerink Partners, Cantor Fitzgerald & Co. and UBS Investment Bank are acting as joint book-running managers for the offering, with JMP Securities as co-manager. Arena Pharmaceuticals is developing small molecule drugs, with its lead compoounds being aimed at treating pulmonary arterial hypertension (PAH), ulcerative colitis (UC), and treatment of pain associated with Crohn's disease.


LATEST HEADLINES

More Headlines

BROWSE ISSUES